Endocrine Abstracts

Introduction: Tight metabolic control reduces the risk of microvascular complications in individuals with type 1 diabetes (T1DM). Multiple studies have shown improvements in quality of life (QOL) in children following the introduction of continuous subcutaneous insulin infusion (CSII) but metabolic outcomes have been more variable. This audit looked at metabolic parameters at long-term follow up in children and adolescents using CSII over 3 years.Methods...

Aim: To investigate the glycaemic control of patients with T1DM before and after the introduction of CSII therapy.Methods: All patients with T1DM receiving CSII therapy for more than 6 months attending the Children’s University Hospital from 2005–2011 were included. Glycosylated haemoglobin (HbA1c) was recorded 12 and 6 months prior to starting therapy, at the time of CSII initiation and annually thereafter. Adverse events and BMI were also rec...